Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-048395

EVP & Chief Commercial Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cheng Sohanya Roshan · EVP & Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-08-31 Grant or award : show line 1 in the form +30,000 119,949 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-08-31 Grant or award : show line 2 in the form Stock Option (right to buy) +45,000 45,000 D
Loading xslF345X03/doc4.xml…